Trade GERN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Geron Corporation (GERN) is trading at US$1.29, down 1.53% today as of Sep 16, 16:00 EDT. The company has a market capitalisation of US$976.56M. Over the past 52 weeks, GERN has traded between US$1.04 and US$2.01. On Syfe you can trade GERN with $0 commission and add it to your watchlist.
| Previous close | US$1.31 |
|---|---|
| Market cap | US$976.56M |
| P/E ratio | 32.12 |
| 52-week range | US$1.04 – US$2.01 |
| Volume | 6.96M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Geron Corporation
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.
Year: 1996
-- Earnings Flash (GERN) Geron Corporation Reports Q2 Revenue $57.5M, vs. FactSet Est of $55.3M
Aug 5, 11:13 AM · MT Newswires
Geron Shares Fall After Reporting Q1 Results
May 6, 1:38 PM · MT Newswires
--Earnings Flash (GERN) Geron Posts Q1 Net Loss $0.01 a Share, vs. FactSet Est of $0.02 Loss
May 6, 11:32 AM · MT Newswires
-- Earnings Flash (GERN) Geron Corporation Reports Q1 Revenue $51.8M
May 6, 11:18 AM · MT Newswires
Geron Corporation (GERN) stock is trading at US$1.29, -1.53% from the previous close of US$1.31.
The market cap for Geron Corporation (GERN) stock is approximately US$976.56M.
The price-to-earnings ratio for Geron Corporation (GERN) is 32.12, based on the latest reported earnings.
The 52-week high for Geron Corporation (GERN) stock is US$2.01.
The 52-week low for Geron Corporation (GERN) stock is US$1.04.
Geron Corporation (GERN) does not currently pay a dividend.
Stay on top of GERN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
